Raoul Nelson
Pediatric Nephrology · Salt Lake City, UTNPI 1972682540
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,499 of the $2,166 with a category attached, or 69.2%. Bayer accounts for 85.4% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $1,851, more than ten times the $4 reported in 2020.
Across 17 payments — averaging $127.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- Novartis$281
- Travere Therapeutics, Inc.$34
Across 133 payments — averaging $6661.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$199K
- Amgen$129K
- Akebia Therapeutics Inc$116K
- Novartis$115K
- Hoffmann-la Roche Limited$106K
- AbbVie$94K
- plus $126K from 4 others
What the payments were for
- Travel & lodging$1,49969%
- Food & beverage$65930%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 11 | $1,851 |
| Novartis | 3 | $281 |
| Travere Therapeutics, Inc. | 3 | $34 |
How this compares
Too few pediatric nephrology providers in Utahto place this figure against a meaningful peer group, so we don't.
Other pediatric nephrology in Salt Lake City
- David HooperSalt Lake City$32K
- Jessica StahlSalt Lake City$2K
- Joseph SherbotieSalt Lake City$154
- Meredith SeamonSalt Lake City$8
- Matthew GrinsellSalt Lake City$4
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.